ID

16201

Descripción

Risedronate in Preventing Bone Loss in Premenopausal Women Receiving Chemotherapy for Primary Breast Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT00054418

Link

https://clinicaltrials.gov/show/NCT00054418

Palabras clave

  1. 5/7/16 5/7/16 -
Subido en

5 de julio de 2016

DOI

Para solicitar uno, por favor iniciar sesión.

Licencia

Creative Commons BY 4.0

Comentarios del modelo :

Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.

Comentarios de grupo de elementos para :

Comentarios del elemento para :

Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.

Eligibility Breast Cancer NCT00054418

Eligibility Breast Cancer NCT00054418

Criteria
Descripción

Criteria

1. premenopausal women
Descripción

Premenopausal

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0279752
≤ 6 months since last menstrual period
Descripción

Time Since last menstrual period

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0040223
UMLS CUI [1,2]
C1711239
UMLS CUI [1,3]
C0425932
no prior bilateral oophorectomy
Descripción

Bilateral oophorectomy

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0278321
not on estrogen replacement therapy
Descripción

Estrogen Replacement Therapy

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0014935
if tah is performed, with at least one intact ovary, or if > 3 months since last menstrual period, then patients must have premenopausal estrogen levels ≤ 1 month of study entry
Descripción

Total abdominal hysterectomy | Ovary One Intact | Time Since last menstrual period | Estrogen Level Premenopausal

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0404079
UMLS CUI [2,1]
C0029939
UMLS CUI [2,2]
C0205447
UMLS CUI [2,3]
C0205266
UMLS CUI [3,1]
C0040223
UMLS CUI [3,2]
C1711239
UMLS CUI [3,3]
C0425932
UMLS CUI [4,1]
C0202006
UMLS CUI [4,2]
C0441889
UMLS CUI [4,3]
C0279752
2. scheduled to undergo adjuvant or neoadjuvant chemotherapy for primary breast cancer (stages i-iiib)
Descripción

Adjuvant Chemotherapy Breast Carcinoma Primary | Neoadjuvant Chemotherapy Breast Carcinoma Primary

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0085533
UMLS CUI [1,2]
C0678222
UMLS CUI [1,3]
C0205225
UMLS CUI [2,1]
C0600558
UMLS CUI [2,2]
C0392920
UMLS CUI [2,3]
C0678222
UMLS CUI [2,4]
C0205225
3. ≥ 18 years of age
Descripción

Age

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0001779
4. ecog performance status (ps) 0 or 1
Descripción

ECOG performance status

Tipo de datos

boolean

Alias
UMLS CUI [1]
C1520224
2. contraindications
Descripción

Medical contraindication

Tipo de datos

boolean

Alias
UMLS CUI [1]
C1301624
1. hypercalcemia (calcium level > 1mg/dl above unl ≤ 6 months
Descripción

Hypercalcemia | Calcium measurement

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0020437
UMLS CUI [2]
C0201925
2. hypocalcemia (calcium level > 0.5 mg/dl below unl ≤ 6 months
Descripción

Hypocalcemia | Calcium measurement

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0020598
UMLS CUI [2]
C0201925
3. inability to stand or sit upright for at least 30 minutes
Descripción

Inability to sit or stand independently Duration

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C3554132
UMLS CUI [1,2]
C0449238
4. known swallowing disorder
Descripción

Deglutition Disorders

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0011168
5. bone mineral density t score of ≤ - 2.0 at the hip or lumbar spine
Descripción

Bone Mineral Density | T score Hip | T score Lumbar spine

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0005938
UMLS CUI [2,1]
C3854607
UMLS CUI [2,2]
C0019552
UMLS CUI [3,1]
C3854607
UMLS CUI [3,2]
C3887615
a patient with a t score of - 2.1 is ineligible
Descripción

T score | Ineligibility

Tipo de datos

boolean

Alias
UMLS CUI [1]
C3854607
UMLS CUI [2]
C1512714
a patient with a t score of - 1.9 is eligible
Descripción

T score | eligible

Tipo de datos

boolean

Alias
UMLS CUI [1]
C3854607
UMLS CUI [2]
C1548635
6. history of vertebral compression fracture
Descripción

Compression fracture of vertebral column

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0262431
exception: traumatic fracture of the coccyx would not exclude a patient from participation
Descripción

Fracture of coccyx Traumatic

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0149860
UMLS CUI [1,2]
C0332663
7. corticosteroids at doses > 5 mg daily of prednison or equivalent for > 2 weeks in the past 6 months
Descripción

Adrenal Cortex Hormones | Prednisone | Prednisone equivalent composition

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0001617
UMLS CUI [2]
C0032952
UMLS CUI [3,1]
C0032952
UMLS CUI [3,2]
C3242803
8. previous treatment with bisphosphonates
Descripción

Diphosphonates

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0012544
9. diseases affecting bone metabolism (hyperthyroidism, hyperparathyroidism, and hypercortisolism)
Descripción

Disease Affecting bone metabolism | Hyperthyroidism | Hyperparathyroidism | Adrenal Gland Hyperfunction

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0012634
UMLS CUI [1,2]
C0392760
UMLS CUI [1,3]
C0596204
UMLS CUI [2]
C0020550
UMLS CUI [3]
C0020502
UMLS CUI [4]
C0001622
10. history of severe renal impairment or creatinine > 2.0 mg/dl
Descripción

Renal Insufficiency Severe | Creatinine measurement, serum

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C1565489
UMLS CUI [1,2]
C0205082
UMLS CUI [2]
C0201976
11. malabsorption syndrome
Descripción

Malabsorption Syndrome

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0024523
12. estrogen replacement therapy
Descripción

Estrogen Replacement Therapy

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0014935
13. oral contraceptive use
Descripción

Oral Contraceptives Use

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0009905
UMLS CUI [1,2]
C1524063
14. prior bilateral oophorectomy
Descripción

bilateral oophorectomy

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0278321
15. pregnant women
Descripción

Pregnancy

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0032961
nursing women
Descripción

Breast Feeding

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0006147
women of childbearing potential who are unwilling to employ adequate contraception (condoms, diaphragm, injections, intrauterine device [iud], surgical sterilization, abstinence, etc.)
Descripción

Childbearing Potential Contraceptive methods Unwilling | Female Condoms | Vaginal contraceptive diaphragm | Contraceptive injection | Intrauterine Devices | Female Sterilization | Sexual Abstinence

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C3831118
UMLS CUI [1,2]
C0700589
UMLS CUI [1,3]
C0558080
UMLS CUI [2]
C0221829
UMLS CUI [3]
C0042241
UMLS CUI [4]
C1656586
UMLS CUI [5]
C0021900
UMLS CUI [6]
C0015787
UMLS CUI [7]
C0036899
this study involves an investigational agent whose genotoxic, mutagenic and teratogenic effects on the developing fetus and newborn are unknown
Descripción

Clinical Trial Involvement with Investigational New Drug | genotoxicity Effect fetus or newborn | Mutagenic effect fetus or newborn | Teratogenic effect fetus or newborn

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0008976
UMLS CUI [1,2]
C1314939
UMLS CUI [1,3]
C0013230
UMLS CUI [2,1]
C0598309
UMLS CUI [2,2]
C1280500
UMLS CUI [2,3]
C1397623
UMLS CUI [3,1]
C0853802
UMLS CUI [3,2]
C1397623
UMLS CUI [4,1]
C0232910
UMLS CUI [4,2]
C1397623
16. dental extraction, root canal, or implants ≤ 3 months prior to registration or planned during study treatment
Descripción

Tooth Extraction | Root Canal Therapy | Dental Prosthesis Implantation | Tooth Extraction Planned | Root Canal Therapy Planned | Dental Prosthesis Implantation Planned

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0040440
UMLS CUI [2]
C0035849
UMLS CUI [3]
C0011370
UMLS CUI [4,1]
C0040440
UMLS CUI [4,2]
C1301732
UMLS CUI [5,1]
C0035849
UMLS CUI [5,2]
C1301732
UMLS CUI [6,1]
C0011370
UMLS CUI [6,2]
C1301732

Similar models

Eligibility Breast Cancer NCT00054418

Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de datos
Alias
Item Group
Premenopausal
Item
1. premenopausal women
boolean
C0279752 (UMLS CUI [1])
Time Since last menstrual period
Item
≤ 6 months since last menstrual period
boolean
C0040223 (UMLS CUI [1,1])
C1711239 (UMLS CUI [1,2])
C0425932 (UMLS CUI [1,3])
Bilateral oophorectomy
Item
no prior bilateral oophorectomy
boolean
C0278321 (UMLS CUI [1])
Estrogen Replacement Therapy
Item
not on estrogen replacement therapy
boolean
C0014935 (UMLS CUI [1])
Total abdominal hysterectomy | Ovary One Intact | Time Since last menstrual period | Estrogen Level Premenopausal
Item
if tah is performed, with at least one intact ovary, or if > 3 months since last menstrual period, then patients must have premenopausal estrogen levels ≤ 1 month of study entry
boolean
C0404079 (UMLS CUI [1])
C0029939 (UMLS CUI [2,1])
C0205447 (UMLS CUI [2,2])
C0205266 (UMLS CUI [2,3])
C0040223 (UMLS CUI [3,1])
C1711239 (UMLS CUI [3,2])
C0425932 (UMLS CUI [3,3])
C0202006 (UMLS CUI [4,1])
C0441889 (UMLS CUI [4,2])
C0279752 (UMLS CUI [4,3])
Adjuvant Chemotherapy Breast Carcinoma Primary | Neoadjuvant Chemotherapy Breast Carcinoma Primary
Item
2. scheduled to undergo adjuvant or neoadjuvant chemotherapy for primary breast cancer (stages i-iiib)
boolean
C0085533 (UMLS CUI [1,1])
C0678222 (UMLS CUI [1,2])
C0205225 (UMLS CUI [1,3])
C0600558 (UMLS CUI [2,1])
C0392920 (UMLS CUI [2,2])
C0678222 (UMLS CUI [2,3])
C0205225 (UMLS CUI [2,4])
Age
Item
3. ≥ 18 years of age
boolean
C0001779 (UMLS CUI [1])
ECOG performance status
Item
4. ecog performance status (ps) 0 or 1
boolean
C1520224 (UMLS CUI [1])
Medical contraindication
Item
2. contraindications
boolean
C1301624 (UMLS CUI [1])
Hypercalcemia | Calcium measurement
Item
1. hypercalcemia (calcium level > 1mg/dl above unl ≤ 6 months
boolean
C0020437 (UMLS CUI [1])
C0201925 (UMLS CUI [2])
Hypocalcemia | Calcium measurement
Item
2. hypocalcemia (calcium level > 0.5 mg/dl below unl ≤ 6 months
boolean
C0020598 (UMLS CUI [1])
C0201925 (UMLS CUI [2])
Inability to sit or stand independently Duration
Item
3. inability to stand or sit upright for at least 30 minutes
boolean
C3554132 (UMLS CUI [1,1])
C0449238 (UMLS CUI [1,2])
Deglutition Disorders
Item
4. known swallowing disorder
boolean
C0011168 (UMLS CUI [1])
Bone Mineral Density | T score Hip | T score Lumbar spine
Item
5. bone mineral density t score of ≤ - 2.0 at the hip or lumbar spine
boolean
C0005938 (UMLS CUI [1])
C3854607 (UMLS CUI [2,1])
C0019552 (UMLS CUI [2,2])
C3854607 (UMLS CUI [3,1])
C3887615 (UMLS CUI [3,2])
T score | Ineligibility
Item
a patient with a t score of - 2.1 is ineligible
boolean
C3854607 (UMLS CUI [1])
C1512714 (UMLS CUI [2])
T score | eligible
Item
a patient with a t score of - 1.9 is eligible
boolean
C3854607 (UMLS CUI [1])
C1548635 (UMLS CUI [2])
Compression fracture of vertebral column
Item
6. history of vertebral compression fracture
boolean
C0262431 (UMLS CUI [1])
Fracture of coccyx Traumatic
Item
exception: traumatic fracture of the coccyx would not exclude a patient from participation
boolean
C0149860 (UMLS CUI [1,1])
C0332663 (UMLS CUI [1,2])
Adrenal Cortex Hormones | Prednisone | Prednisone equivalent composition
Item
7. corticosteroids at doses > 5 mg daily of prednison or equivalent for > 2 weeks in the past 6 months
boolean
C0001617 (UMLS CUI [1])
C0032952 (UMLS CUI [2])
C0032952 (UMLS CUI [3,1])
C3242803 (UMLS CUI [3,2])
Diphosphonates
Item
8. previous treatment with bisphosphonates
boolean
C0012544 (UMLS CUI [1])
Disease Affecting bone metabolism | Hyperthyroidism | Hyperparathyroidism | Adrenal Gland Hyperfunction
Item
9. diseases affecting bone metabolism (hyperthyroidism, hyperparathyroidism, and hypercortisolism)
boolean
C0012634 (UMLS CUI [1,1])
C0392760 (UMLS CUI [1,2])
C0596204 (UMLS CUI [1,3])
C0020550 (UMLS CUI [2])
C0020502 (UMLS CUI [3])
C0001622 (UMLS CUI [4])
Renal Insufficiency Severe | Creatinine measurement, serum
Item
10. history of severe renal impairment or creatinine > 2.0 mg/dl
boolean
C1565489 (UMLS CUI [1,1])
C0205082 (UMLS CUI [1,2])
C0201976 (UMLS CUI [2])
Malabsorption Syndrome
Item
11. malabsorption syndrome
boolean
C0024523 (UMLS CUI [1])
Estrogen Replacement Therapy
Item
12. estrogen replacement therapy
boolean
C0014935 (UMLS CUI [1])
Oral Contraceptives Use
Item
13. oral contraceptive use
boolean
C0009905 (UMLS CUI [1,1])
C1524063 (UMLS CUI [1,2])
bilateral oophorectomy
Item
14. prior bilateral oophorectomy
boolean
C0278321 (UMLS CUI [1])
Pregnancy
Item
15. pregnant women
boolean
C0032961 (UMLS CUI [1])
Breast Feeding
Item
nursing women
boolean
C0006147 (UMLS CUI [1])
Childbearing Potential Contraceptive methods Unwilling | Female Condoms | Vaginal contraceptive diaphragm | Contraceptive injection | Intrauterine Devices | Female Sterilization | Sexual Abstinence
Item
women of childbearing potential who are unwilling to employ adequate contraception (condoms, diaphragm, injections, intrauterine device [iud], surgical sterilization, abstinence, etc.)
boolean
C3831118 (UMLS CUI [1,1])
C0700589 (UMLS CUI [1,2])
C0558080 (UMLS CUI [1,3])
C0221829 (UMLS CUI [2])
C0042241 (UMLS CUI [3])
C1656586 (UMLS CUI [4])
C0021900 (UMLS CUI [5])
C0015787 (UMLS CUI [6])
C0036899 (UMLS CUI [7])
Clinical Trial Involvement with Investigational New Drug | genotoxicity Effect fetus or newborn | Mutagenic effect fetus or newborn | Teratogenic effect fetus or newborn
Item
this study involves an investigational agent whose genotoxic, mutagenic and teratogenic effects on the developing fetus and newborn are unknown
boolean
C0008976 (UMLS CUI [1,1])
C1314939 (UMLS CUI [1,2])
C0013230 (UMLS CUI [1,3])
C0598309 (UMLS CUI [2,1])
C1280500 (UMLS CUI [2,2])
C1397623 (UMLS CUI [2,3])
C0853802 (UMLS CUI [3,1])
C1397623 (UMLS CUI [3,2])
C0232910 (UMLS CUI [4,1])
C1397623 (UMLS CUI [4,2])
Tooth Extraction | Root Canal Therapy | Dental Prosthesis Implantation | Tooth Extraction Planned | Root Canal Therapy Planned | Dental Prosthesis Implantation Planned
Item
16. dental extraction, root canal, or implants ≤ 3 months prior to registration or planned during study treatment
boolean
C0040440 (UMLS CUI [1])
C0035849 (UMLS CUI [2])
C0011370 (UMLS CUI [3])
C0040440 (UMLS CUI [4,1])
C1301732 (UMLS CUI [4,2])
C0035849 (UMLS CUI [5,1])
C1301732 (UMLS CUI [5,2])
C0011370 (UMLS CUI [6,1])
C1301732 (UMLS CUI [6,2])

Utilice este formulario para comentarios, preguntas y sugerencias.

Los campos marcados con * son obligatorios.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial